Literature DB >> 15749819

The cellular HIV-1 Rev cofactor hRIP is required for viral replication.

Zhong Yu1, Nuria Sánchez-Velar, Irina E Catrina, Ellen L W Kittler, Enyeneama B Udofia, Maria L Zapp.   

Abstract

An important goal of contemporary HIV type 1 (HIV-1) research is to identify cellular cofactors required for viral replication. The HIV-1 Rev protein facilitates the cytoplasmic accumulation of the intron-containing viral gag-pol and env mRNAs and is required for viral replication. We have previously shown that a cellular protein, human Rev-interacting protein (hRIP), is an essential Rev cofactor that promotes the release of incompletely spliced HIV-1 RNAs from the perinuclear region. Here, we use complementary genetic approaches to ablate hRIP activity and analyze HIV-1 replication and viral RNA localization. We find that ablation of hRIP activity by a dominant-negative mutant or RNA interference inhibits virus production by mislocalizing Rev-directed RNAs to the nuclear periphery. We further show that depletion of endogenous hRIP by RNA interference results in the loss of viral replication in human cell lines and primary macrophages; virus production was restored to wild-type levels after reintroduction of hRIP protein. Taken together, our results indicate that hRIP is an essential cellular cofactor for Rev function and HIV-1 replication. Because hRIP is not required for cell viability, it may be an attractive target for the development of new antiviral strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749819      PMCID: PMC552779          DOI: 10.1073/pnas.0408889102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Tsg101: HIV-1's ticket to ride.

Authors:  Carol A Carter
Journal:  Trends Microbiol       Date:  2002-05       Impact factor: 17.079

2.  Developments in HIV therapeutics.

Authors:  Brian A Boyle
Journal:  AIDS Read       Date:  2004-08

Review 3.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

Review 4.  HIV chemotherapy.

Authors:  D D Richman
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

5.  Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

Authors:  S R Bartz; M E Rogel; M Emerman
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

6.  The protein network of HIV budding.

Authors:  Uta K von Schwedler; Melissa Stuchell; Barbara Müller; Diane M Ward; Hyo-Young Chung; Eiji Morita; Hubert E Wang; Thaylon Davis; Gong-Ping He; Daniel M Cimbora; Anna Scott; Hans-Georg Kräusslich; Jerry Kaplan; Scott G Morham; Wesley I Sundquist
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

7.  Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast.

Authors:  F Stutz; M Neville; M Rosbash
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

8.  AP-2/Eps15 interaction is required for receptor-mediated endocytosis.

Authors:  A Benmerah; C Lamaze; B Bègue; S L Schmid; A Dautry-Varsat; N Cerf-Bensussan
Journal:  J Cell Biol       Date:  1998-03-09       Impact factor: 10.539

9.  Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes.

Authors:  H E Gendelman; J M Orenstein; M A Martin; C Ferrua; R Mitra; T Phipps; L A Wahl; H C Lane; A S Fauci; D S Burke
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  The eps15 homology (EH) domain-based interaction between eps15 and hrb connects the molecular machinery of endocytosis to that of nucleocytosolic transport.

Authors:  M Doria; A E Salcini; E Colombo; T G Parslow; P G Pelicci; P P Di Fiore
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

View more
  23 in total

1.  Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection.

Authors:  Amie J Eisfeld; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 2.  RNA interference and antiviral therapy.

Authors:  Yan Ma; Chu-Yan Chan; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

3.  Translational regulation of HIV-1 replication by HIV-1 Rev cellular cofactors Sam68, eIF5A, hRIP, and DDX3.

Authors:  Jinfeng Liu; Jorge Henao-Mejia; Hao Liu; Yingren Zhao; Johnny J He
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-01       Impact factor: 4.147

4.  Genetic variants associated with severe pneumonia in A/H1N1 influenza infection.

Authors:  J Zúñiga; I Buendía-Roldán; Y Zhao; L Jiménez; D Torres; J Romo; G Ramírez; A Cruz; G Vargas-Alarcon; C-C Sheu; F Chen; L Su; A M Tager; A Pardo; M Selman; D C Christiani
Journal:  Eur Respir J       Date:  2011-07-07       Impact factor: 16.671

5.  The temporally controlled expression of Drongo, the fruit fly homolog of AGFG1, is achieved in female germline cells via P-bodies and its localization requires functional Rab11.

Authors:  Irina E Catrina; Livia V Bayer; Giussepe Yanez; John M McLaughlin; Kornelia Malaczek; Ekaterina Bagaeva; Salvatore A E Marras; Diana P Bratu
Journal:  RNA Biol       Date:  2016-08-11       Impact factor: 4.652

Review 6.  DEAD-box helicases: posttranslational regulation and function.

Authors:  Eric A Gustafson; Gary M Wessel
Journal:  Biochem Biophys Res Commun       Date:  2010-03-03       Impact factor: 3.575

7.  A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles.

Authors:  Laura Brandano; Mario Stevenson
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

8.  HIV-1 Rev-binding protein accelerates cellular uptake of iron to drive Notch-induced T cell leukemogenesis in mice.

Authors:  Shariq S Khwaja; Hudan Liu; Caili Tong; Fang Jin; Warren S Pear; Jan van Deursen; Richard J Bram
Journal:  J Clin Invest       Date:  2010-07       Impact factor: 14.808

9.  Intracellular transport of human immunodeficiency virus type 1 genomic RNA and viral production are dependent on dynein motor function and late endosome positioning.

Authors:  Martin Lehmann; Miroslav P Milev; Levon Abrahamyan; Xiao-Jian Yao; Nelly Pante; Andrew J Mouland
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

10.  Heterocyclic compounds that inhibit Rev-RRE function and human immunodeficiency virus type 1 replication.

Authors:  Deidra Shuck-Lee; Fei Fei Chen; Ryan Willard; Sharmila Raman; Roger Ptak; Marie-Louise Hammarskjold; David Rekosh
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.